GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Return-on-Tangible-Asset

Awakn Life Sciences (Awakn Life Sciences) Return-on-Tangible-Asset : -270.88% (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Awakn Life Sciences's annualized Net Income for the quarter that ended in Oct. 2023 was $-1.89 Mil. Awakn Life Sciences's average total tangible assets for the quarter that ended in Oct. 2023 was $0.70 Mil. Therefore, Awakn Life Sciences's annualized Return-on-Tangible-Asset for the quarter that ended in Oct. 2023 was -270.88%.

The historical rank and industry rank for Awakn Life Sciences's Return-on-Tangible-Asset or its related term are showing as below:

AWKNF' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -474.44   Med: -178.68   Max: -134.06
Current: -213.85

During the past 3 years, Awakn Life Sciences's highest Return-on-Tangible-Asset was -134.06%. The lowest was -474.44%. And the median was -178.68%.

AWKNF's Return-on-Tangible-Asset is ranked worse than
91.9% of 1555 companies
in the Biotechnology industry
Industry Median: -39.47 vs AWKNF: -213.85

Awakn Life Sciences Return-on-Tangible-Asset Historical Data

The historical data trend for Awakn Life Sciences's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Return-on-Tangible-Asset Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23
Return-on-Tangible-Asset
-134.10 -474.92 -172.37

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -125.07 -231.72 -145.28 -272.49 -270.88

Competitive Comparison of Awakn Life Sciences's Return-on-Tangible-Asset

For the Biotechnology subindustry, Awakn Life Sciences's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Return-on-Tangible-Asset falls into.



Awakn Life Sciences Return-on-Tangible-Asset Calculation

Awakn Life Sciences's annualized Return-on-Tangible-Asset for the fiscal year that ended in Jan. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Jan. 2023 )  (A: Jan. 2022 )(A: Jan. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Jan. 2023 )  (A: Jan. 2022 )(A: Jan. 2023 )
=-6.812/( (4.672+3.232)/ 2 )
=-6.812/3.952
=-172.37 %

Awakn Life Sciences's annualized Return-on-Tangible-Asset for the quarter that ended in Oct. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Oct. 2023 )  (Q: Jul. 2023 )(Q: Oct. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Oct. 2023 )  (Q: Jul. 2023 )(Q: Oct. 2023 )
=-1.888/( (0.635+0.759)/ 2 )
=-1.888/0.697
=-270.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Oct. 2023) net income data.


Awakn Life Sciences  (OTCPK:AWKNF) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Awakn Life Sciences Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines